Using Gold Nanoparticles for Vaccine Delivery

An international team of researchers has been able to demonstrate the impact of nanoparticles on human B lymphocytes, the immune cells responsible for antibody production. The results of their research, published in the journal ACS Nano, could lead to more effective vaccines and other therapeutics. Nanoparticles as Vaccine ‘Vehicles’ Because B lymphocytes are responsible for 

Continue Reading…

Using Nanobodies to Improve CAR T-Cell Therapy

Researchers at Boston Children’s Hospital and MIT have recently been able to show that mini-antibodies called nanobodies – previously discovered more than 20 years ago – may be able to resolve an issue in the cancer field: making chimeric antigen receptor (CAR) T-cell therapies functional in solid tumors. Their research was published in the journal 

Continue Reading…

A Future Focus for Parkinson’s Treatment

In a study published by the Journal of Biological Chemistry, scientists at UPenn School of Veterinary Medicine discovered that the enzyme cytochrome P450 2D6 (CYP2D6) plays a role in triggering Parkinson’s disease and represents a new focus for Parkinson’s treatment. Chemically induced Parkinson’s A few decades ago, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was found to induce the onset 

Continue Reading…